FMCSA action against 2 doctors threatens licenses of over 15,000 truckers
WASHINGTON — The Federal Motor Carrier Safety Administration has voided thousands of medical examiner certificates issued by two Houston-area doctors, putting the livelihoods of over 15,000 commercial drivers at risk.
A 'high volume' of physical examinations performed by Dr. Jenny Le (Medical Examiner National Registry No. 4762579227) and Dr. Dustin Mai (National Registry No. 7120983977) between March 2023 and March 2025 raised red flags at FMCSA, which referred the matter to the Transportation Department's Office of Inspector General, according to the agency.
DOT subsequently collaborated with the FBI and the Homeland Security Department for further investigation, after which FMCSA found that Drs. Le and Mai 'failed to correctly apply required standards in determining that drivers are physically qualified to operate a CMV (commercial motor vehicle).'
On Thursday, FMCSA voided 'over 15,000 unexpired Medical Examiner's Certificates (MECs) issued by Dr. Le and Dr. Mai between March 2023 and March 2025 – an action that affected 15,225 commercial motor vehicle drivers,' the agency announced on Friday.FMCSA stated that while the decision does not immediately make an affected driver unqualified to drive a truck, drivers who received their MECs from the two medical examiners must get a new certificate by May 10 from an active medical examiner listed on the National Registry.
FMCSA warned, however, that 'if a driver fails to obtain a new certificate by the identified date, the driver's respective state drivers licensing agency (SDLA) will initiate procedures to downgrade the driver's CDL.'
'FMCSA's primary mission is to enhance safety on our nation's roadways,' said FMCSA Chief Counsel Jesse Elison, the effective leader of the agency while it awaits formal confirmation of an administrator.
'Removing non-compliant medical examiners from the National Registry is a necessary step to maintain the integrity of the medical certification process and ensure that only qualified, properly trained professionals are certifying the physical qualifications of commercial motor vehicle drivers.'780,000 driver medical exams could be missing from FMCSA database
How do trucking medical examiners stay certified?
FMCSA updates guidance for truck driver medical examiners
Click for more FreightWaves articles by John Gallagher.
The post FMCSA action against 2 doctors threatens licenses of over 15,000 truckers appeared first on FreightWaves.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Here's what to know about the twice-yearly preventative HIV shot
The Food and Drug Administration has approved a twice-yearly preventive HIV shot that could protect millions from the virus. People at risk for HIV may choose to take PrEP, a medication that helps prevent HIV infection. PrEp has been prescribed as a daily pill or a shot given every two months. This new twice-yearly drug called lenacapavir is now the longest-lasting type of PrEP. Ian Haddock, a Houston man who participated in a study of the drug, told The Associated Press it 'expands the opportunity for prevention.' 'Now I forget that I'm on PrEP because I don't have to carry around a pill bottle,' he said. The shot, made by Gilead Sciences, is injected under the skin of the abdomen. It leaves a small 'depot' of medication that slowly absorbs into the body. 'This really has the possibility of ending HIV transmission,' Greg Millett, public policy director at amfAR, The Foundation for AIDS Research, told the AP. But the upheaval in U.S. healthcare — including cuts to public health agencies and Medicaid — and slashing of American foreign aid to fight HIV are clouding the prospects. Millett said "gaping holes in the system" in the U.S. and globally "are going to make it difficult for us to make sure we not only get lenacapavir into people's bodies but make sure they come back' even as little as twice a year. Gilead's drug already is sold to treat HIV under the brand name Sunlenca. The prevention dose will be sold under a different name, Yeztugo. Gilead didn't immediately announce its price. The drug only prevents HIV transmission – it doesn't block other sexually transmitted diseases. Global efforts at ending the HIV pandemic by 2030 have stalled. There still are more than 30,000 new infections in the U.S. each year and about 1.3 million worldwide. Only about 400,000 Americans already use some form of PrEP, a fraction of those estimated to benefit. A recent study found states with high use of PrEP saw a decrease in HIV infections, while rates continued rising elsewhere. About half of new infections are in women, who often need protection they can use without a partner's knowledge or consent. One rigorous study in South Africa and Uganda compared more than 5,300 sexually active young women and teen girls given twice-yearly lenacapavir or the daily pills. There were no HIV infections in those receiving the shot while about 2% in the comparison group caught HIV from infected sex partners. A second study found the twice-yearly shot nearly as effective in gay men and gender-nonconforming people in the U.S. and in several other countries hard-hit by HIV. Haddock, who leads the Normal Anomaly Initiative, a nonprofit serving Black LGBTQ+ communities, had tried PrEP off and on since 2015 but he jumped at the chance to participate in the lenacapavir study and continues with the twice-yearly shots as part of the research follow-up. 'Men, women, gay, straight – it really just kinds of expands the opportunity for prevention,' he added. Just remembering a clinic visit every six months 'is a powerful tool versus constantly having to talk about, like, condoms, constantly making sure you're taking your pill every day.' 'Everyone in every country who's at risk of HIV needs access to PrEP,' Dr. Gordon Crofoot of Houston, who helped lead the study in men, told the AP. 'We need to get easier access to PrEP that's highly effective like this is.'
Business Journals
2 hours ago
- Business Journals
Crozer Health closure: Why local health systems' rescue plan failed
A coalition of six Philadelphia-area health systems spent months working on a way to rescue Crozer Health, but according to those involved in the discussions, the deal was thwarted by two primary obstacles.
Time Business News
2 days ago
- Time Business News
Should You Hire a Driver After SAP Program Completion? Pros and Cons for 2025
Should you hire a driver after SAP program completion? This is a common question many fleet managers and employers in the trucking industry are asking in 2025. With FMCSA and DOT compliance requirements growing stricter, understanding the benefits and risks of hiring SAP-cleared drivers is essential for making informed staffing decisions. The DOT SAP Program (Substance Abuse Professional Program) is designed to rehabilitate drivers who violated drug and alcohol policies. After successful SAP program completion, these drivers are legally eligible to return to safety-sensitive duties — but does that mean you should immediately put them back on the road? ✔ For complete guidance on DOT SAP compliance, visit our DOT SAP Program page. Drivers who finish the SAP process meet DOT's Return-to-Duty standards, ensuring your company remains legally compliant. Drivers given a second chance may demonstrate improved loyalty and commitment, reducing turnover risks. SAP-cleared drivers are subject to follow-up testing, making them one of the most monitored groups on the road — reducing immediate safety concerns. ✔ Learn more about SAP Evaluation to understand the process drivers undergo. Some insurers may raise premiums if your fleet includes drivers with past DOT violations, impacting operational costs. Despite SAP clearance, employers may still worry about reliability or potential relapse, affecting team trust. Clients or partners may view employing SAP-cleared drivers as a liability, influencing business relationships. Employers have the right to make hiring decisions even after SAP program completion but cannot discriminate solely based on past SAP participation. Decisions must align with EEOC guidelines and internal company policies. ✔ For a detailed compliance guide, check the FMCSA Clearinghouse Rules. Q1: Is it mandatory to rehire a driver after SAP program completion? No, employers are not legally required to rehire SAP-cleared drivers but must document valid, non-discriminatory reasons for refusal. Q2: Does SAP program completion erase a driver's past violation from records? No. The violation remains on file in the FMCSA Clearinghouse for five years or until follow-up testing is complete. Q3: Can a driver apply to other companies after SAP program completion? Yes, drivers are free to seek employment elsewhere, but all prospective employers must review Clearinghouse records. Deciding whether to hire a driver after SAP program completion requires balancing safety, cost, legal compliance, and company culture. While SAP-cleared drivers meet DOT standards, your final decision should align with fleet risk management goals. For trusted DOT SAP Evaluation and employer compliance solutions, visit: 🔗 Or explore SAP services at: 🔗 TIME BUSINESS NEWS
